Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2018

Nov 2, 2018

30150_dirs_2018-11-02_8d01f4ef-51fe-4679-ad29-ad90d5a0c733.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2018-11-01

Reporting Person: Adsett Roger (Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-01 Common Stock P 3000 $15.969 Acquired 18594 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $15.95 to $15.98. The prices reported above reflect the weighted average price. The number of shares sold at each separate price will be made available to the SEC staff, the issuer or a security holder of the issuer upon request.